Active ingredientNiraparibCat. No. P-N070-001CAS 1038915-60-4Family · Pharmaceutical analytical standards
Niraparib
An oral inhibitor of PARP, the enzyme that helps cells repair damaged DNA: approved in 2017 in the United States and Europe as maintenance therapy for ovarian cancer. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?It was discovered in Italy, at a research centre in Pomezia, near Rome. The suffix -parib, shared by the whole class, refers to the PARP enzyme that these medicines block.
Go to the active ingredient →Active ingredientNiraparibCat. No. P-N070-001CAS 1038915-60-4
Isotopically labelledNiraparib-d5Cat. No. P-N070-004
NitrosamineN-Nitroso NiraparibCat. No. P-N070-005
Impurity4-(3-Piperidinyl)benzenamineCat. No. P-N070-007CAS 1196713-21-9
Impurity5-(4-Bromophenyl)-2-piperidoneCat. No. P-N070-009CAS 946076-73-9
ImpurityNiraparib Impurity 1Cat. No. P-N070-010CAS 68109-89-7
Impurityent-NiraparibCat. No. P-N070-011CAS 1038915-58-0
ImpurityNiraparib Impurity 2Cat. No. P-N070-012CAS 93247-79-1
ImpurityNiraparib Carboxylic AcidCat. No. P-N070-013CAS 1476777-06-6
ImpurityNiraparib Impurity 3Cat. No. P-N070-015CAS 2308483-83-0
ImpurityNiraparib Impurity 4Cat. No. P-N070-016CAS 2308483-85-2
ImpurityNiraparib Impurity 5Cat. No. P-N070-017CAS 1476776-44-9
Impurityrac-NiraparibCat. No. P-N070-018CAS 1038915-75-1
ImpurityNiraparib Impurity 6Cat. No. P-N070-019CAS 1263284-59-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.